Levi Strauss Shocks Wall Street: Denim Demand Soars, Forecast Raised – Why LEVI Stock Still Slipped

Levi Strauss Shocks Wall Street: Denim Demand Soars, Forecast Raised – Why LEVI Stock Still Slipped

Blockbuster Q3 Earnings – Sales Beat and Outlook Raised Levi Strauss & Co. delivered strong third-quarter 2025 results, topping estimates and defying retail sector headwinds. Revenue for Q3 (June–August 2025) hit $1.54 billion, up 7% year-on-year and slightly above analyst expectations of ~$1.50 billionreuters.comtipranks.com. Adjusted earnings were $0.34 per share, a penny higher than a year ago and beating the $0.31 consensus estimatetipranks.com. The company achieved broad-based growth across channels, regions, and product categories. Direct-to-consumer (DTC) sales – through Levi’s own stores and website – surged +11%(organically +9%), now making up 46% of total revenuebenzinga.combenzinga.com. Notably, e-commerce sales jumped 16% as Levi’s leaned into online and full-price sellingreuters.com. This quarter showcased improving profitability. Gross margin expanded 61.7% (up
10 October 2025
New Era Energy & Digital (NUAI) Stock Skyrockets on AI Data Center Dreams – Key Updates & Outlook

New Era Energy & Digital (NUAI) Stock Skyrockets on AI Data Center Dreams – Key Updates & Outlook

Latest Developments & October Stock Surge After a quiet summer, New Era Energy & Digital’s stock exploded in early October 2025 on the back of major project news and aggressive investor outreach. On October 9, NUAI shares nearly doubled intraday – a one-day jump of roughly 80% – following fresh updates on its West Texas data center ventureau.investing.com. The rally took the stock from around $1.54 to roughly $2.8–$2.9, on extraordinarily heavy volume. This kind of move echoed the late-September spike when NUAI announced completion of Phase One engineering; at that time, the stock closed +49.8% in a single session (Sept. 25) as retail traders piled
Costco Stock Surges Amid Retail Gloom – Will $900+ Shares Keep Climbing?

Costco Stock Soars Amid Retail Gloom – What’s Driving the Rally and Will It Last?

Stock Price & Recent Performance Costco’s stock has been on a long-term upward climb, and 2025 is no exception – though it hasn’t been a smooth ride. After a strong rally in the first half of the year, Costco (COST) shares reached an intraday record high around $1,078earlier in 2025ts2.tech. Enthusiasm was fueled by robust sales growth and a broader market rally. However, by late summer the stock had pulled back into the mid-$900s amid some profit-taking and market volatilityts2.tech. As of October 9, 2025, COST trades in the $914–$928 rangets2.tech – essentially back to where it started the year (roughly flat year-to-date
9 October 2025
USA Rare Earth Stock Skyrockets on Rare Earth Boom and White House Buzz – What’s Driving USAR’s Record High?

USA Rare Earth (USAR) Stock Soars on Rare Earth Boom and White House Buzz – What Investors Need to Know

Company Background & Operations USA Rare Earth, Inc. is a U.S.-based critical minerals company focused on establishing a fully domestic rare-earth supply chain – from mining and processing raw rare earth elements to manufacturing finished rare-earth magnets. The company’s flagship asset is the Round Top Mountain rare-earth deposit in Texas, which contains a broad range of critical rare earth elements (including heavy REEs like dysprosium and terbium)ts2.tech. Through a joint venture (with Texas Mineral Resources), USAR controls the Round Top deposit, which is still under development but is central to securing the raw materials for its magnet production plansts2.tech. On the downstream side, USA Rare Earth
BULLISH BREAKOUT: Google’s $3B Backstop Rockets TeraWulf (WULF) Stock to Multi-Year High

BULLISH BREAKOUT: Google’s $3B Backstop Rockets TeraWulf (WULF) Stock to Multi-Year High

Recent Developments Google-Backed AI Deals: In mid-August 2025 TeraWulf unveiled two 10-year co-location agreements with Fluidstack for AI workloads investors.terawulf.com investors.terawulf.com. These contracts (200+ MW at Lake Mariner) anchor ~$3.7 B of initial revenue (up to $8.7 B with extensions) investors.terawulf.com. Google Inc. agreed to backstop $1.8 B of Fluidstack’s lease obligations and took warrants for ~41 M shares (~8% equity) investors.terawulf.com. Shortly after, Google deepened its commitment: on Aug.18 it provided an additional $1.4 B backstop, gaining warrants for ~32.5 M more shares (bringing its total commitment to $3.2 B and stake to 14%) ts2.tech bitget.com. The new funding secures project debt financing for the CB-5
9 October 2025
Snowflake Stock Rockets to Record High on AI Surge – Can $300 Targets Be Next?

Snowflake Stock Rockets to Record High on AI Surge – Can $300 Targets Be Next?

Snowflake’s shares have been on a tear through late 2025. After soaring on its strong Q2 report, SNOW traded near $247 on Oct 9 – close to its year‑high ts2.tech. That represents triple‑digit gains versus a year ago ts2.tech. The uptrend is driven by accelerating revenue growth and the cloud/AI hype cycle. Technically, the stock is extended (above its 50-day and 200-day moving averages around $216 and $197 marketbeat.com) but momentum remains strong. In the near term, investors will watch whether SNOW can sustain this pace or needs to consolidate around $250. On the fundamental side, Snowflake’s Q2 results underscore
Bitfarms Stock Explodes on Crypto & AI Boom – 148% YTD Rally

Bitfarms Stock Explodes on Crypto & AI Boom – 148% YTD Rally

Business Model and Operations Bitfarms is a “vertically integrated” Bitcoin miner: it builds, owns and operates its mining farms end-to-end investor.bitfarms.com. The company operates about 13 data centers (10 owned farms plus hosting agreements) across four countries investor.bitfarms.com. These facilities house thousands of ASIC miners powered mostly by hydro-electric and other long-term renewable contracts – Bitfarms boasts 82–90% renewable energy use investor.bitfarms.com ainvest.com. In-house teams handle electrical engineering, installation, and repairs investor.bitfarms.com. As of mid-2025, Bitfarms had ~17–19 EH/s of operational hashing capacity (after acquiring Stronghold Digital Mining, which added ~1 GW of U.S. projects cantechletter.com). This makes it one of North
AtlasClear (ATCH) Stock Skyrockets 50% on $20M Financing – Fintech Underdog Poised to Soar?

AtlasClear (ATCH) Stock Skyrockets 50% on $20M Financing – Fintech Underdog Poised to Soar?

Business Model & Market Position AtlasClear is a niche B2B fintech aiming to offer a one-stop clearing, brokerage and banking platform for smaller financial firms. According to the company, it is “building a cutting-edge, technology-enabled financial services platform to modernize trading, clearing, settlement and banking” globenewswire.com. Through its subsidiary Wilson-Davis & Co. (a full-service broker-dealer since 1968) AtlasClear provides correspondent clearing and trade execution. Management’s strategy is to expand this platform organically and via acquisitions: for example, it plans to acquire Commercial Bancorp of Wyoming (Farmers State Bank), a Federal Reserve member bank streetinsider.com, to gain FDIC/banking capabilities. The combined
9 October 2025
Shocking IRS Update: New 2026 Tax Brackets Slashed for Millions – Here’s How Much You’ll Save

Shocking IRS Update: New 2026 Tax Brackets Slashed for Millions – Here’s How Much You’ll Save

The IRS announced inflation-adjusted 2026 tax brackets and deductions, easing bracket creep irs.gov cbsnews.com. For example, a single earner making $50,000 will now fall in the 12% bracket (instead of 22%) cbsnews.com. The standard deduction rises to $32,200 for joint filers ($16,100 single) irs.gov. All seven marginal rates (10%–37%) remain in force under the new law, but higher income cutoffs apply irs.gov. Capital gains thresholds also jump: the 0% rate applies up to ~$49,450 (single) or $98,900 (couples) thefinancebuff.com, and the 15% bracket extends to ~$545,500/$613,700 thefinancebuff.com. These changes stem from the new “One Big Beautiful Bill” law (signed July
9 October 2025
CIFR Stock Skyrockets 320% After Google-Backed AI Mining Deal – Bubble or Boom?

CIFR Stock Skyrockets 320% After Google-Backed AI Mining Deal – Bubble or Boom?

Company Background & Business Model Cipher Mining is a pure-play Bitcoin miner that specializes in large-scale, energy-efficient data-center mining ts2.tech. It locates facilities “behind the meter” at low-cost renewable power sites in West Texas ts2.tech. Its flagship “Black Pearl” complex (Odessa, TX) is a 150 MW facility serving both Bitcoin mining and high-performance computing (HPC) ts2.tech. As of mid-2025, Cipher had deployed ~16.8 EH/s of mining capacity (with next-gen ASIC miners) ts2.tech and plans to reach ~23.5 EH/s by Q3’25 ts2.tech. To fund growth, it has a large 2.6 GW pipeline of additional power projects ts2.tech. In Q2’25 Cipher produced ~150 BTC and achieved $44 M
9 October 2025
MEDIROM (NASDAQ: MRM) Set for Takeoff: Series A Boost & Altman-Backed ‘Orb’ Deal Fuels 150% Upside

MEDIROM (NASDAQ: MRM) Set for Takeoff: Series A Boost & Altman-Backed ‘Orb’ Deal Fuels 150% Upside

Company Background & Business Model MEDIROM Healthcare Technologies (NASDAQ: MRM) is a Tokyo‑based provider of holistic health and wellness services. Founded in 2000, it operates 300+ Re.Ra.Ku branded relaxation salons across Japan medirom.co.jp, offering massage, aromatherapy and lifestyle therapy. These salons generate the bulk of revenues (47.3M of $52.7M in 2024) ir.medirom.co.jp. In parallel, since 2015 MEDIROM has built a Digital Preventative Healthcare arm. Key elements are: the Lav® on-demand health‐guidance app, and the MOTHER Bracelet®, a battery‑free wearable activity tracker. In 2023 it launched REMONY, a remote health monitoring service bundling the MOTHER Bracelet with corporate wellness programs medirom.co.jp.
9 October 2025
Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Sources: Akero Therapeutics investor materials; Novo Nordisk press statements; Reuters, TS2.tech and FierceBiotechnews reportsts2.techts2.techfiercebiotech.com; MarketBeat and DirectorsTalk analyst surveysmarketbeat.comdirectorstalkinterviews.com; Economic Times deal summaryeconomictimes.indiatimes.comeconomictimes.indiatimes.com; Business Wire legal alertbusinesswire.combusinesswire.com; and TradingView market datamarketbeat.comtradingview.com.
Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Company Profile – Background & Leadership Turn Therapeutics, Inc. is a Westlake Village, CA-based biotech company founded in 2015renaissancecapital.com. The company (formerly named Global Health Solutions, Inc.) officially rebranded to Turn Therapeutics in Sept 2025 ahead of its Nasdaq listingstockanalysis.com. Turn’s mission is to “turn the tides” in medicine by developing technologies that heal, not just manage, challenging traditional treatmentsbenzinga.com. CEO Bradley Burnam (the founder) leads a lean operation “built on a shoestring, with an absolute disdain for waste,” as he emphasized during the Nasdaq bell-ringing ceremonybenzinga.com. Burnam and his team bring a “patient-first” approach and a frugal business model to drug development, aiming to maximize R&D output
Intellia Therapeutics Stock Soars on Gene-Editing Breakthrough – Analysts Eye 70–100% Upside

Intellia Therapeutics Stock Soars on Gene-Editing Breakthrough – Analysts Eye 70–100% Upside

Intellia Background and Pipeline Intellia was an early pioneer of in-vivo CRISPR therapy. Based in Cambridge, MA, it was among the first to administer CRISPR-Cas9 therapies directly into patients ts2.tech. In 2021 Intellia reported the first clinical proof that in-body CRISPR editing could work – a single injection dramatically lowered the disease protein (transthyretin) in ATTR amyloidosis patients ts2.tech. Today, the company’s focus is on curative gene edits in severe diseases. Its lead programs are NTLA-2001 (nexiguran ziclumeran) for transthyretin amyloidosis (ATTR) and NTLA-2002 (lonvoguran ziclumeran) for hereditary angioedema (HAE) ts2.tech ts2.tech. Both use CRISPR delivered via lipid nanoparticles to
9 October 2025
Uzbekistan’s Big Bet: Import Fair 2025 Sparks a ‘Made in Uzbekistan’ Boom

Uzbekistan’s Big Bet: Import Fair 2025 Sparks a ‘Made in Uzbekistan’ Boom

Import Fair 2025: Turning Imports into Local Industry Uzbekistan’s capital Tashkent buzzed with business activity as the country opened the First International Uzbek Import Fair 2025. The exhibition, held at the Uzexpocentre on October 7–9, is a cornerstone of President Shavkat Mirziyoyev’s industrial strategy to boost local production. Deputy PM Jamshid Khodjaev, inaugurating the fair, emphasized its mission to deepen industrial cooperation, support domestic manufacturers, and promote import substitution uzdaily.uz. The theme “Optimizing Imports and Increasing Local Content” underscores a shift in policy: instead of curbing imports via tariffs or bans, Uzbekistan wants to partner with foreign firms to produce
9 October 2025
United Airlines Stock Skyrockets on Travel Boom: Is $130 Next for UAL?

United Airlines Stock Skyrockets on Travel Boom: Is $130 Next for UAL?

Stock Price & Recent Performance As of market close Oct 8, 2025, UAL traded around $98.09 reuters.com, a ~1.5% gain for the day. In early pre-market Oct 9, it had jumped ~6% to ~$104 stockanalysis.com. Over the past week, UAL shares have rebounded from recent lows near ~$94 (Oct 2) to fresh highs around $99–100. The stock’s 6-month chart shows a rally to a mid-September peak (~$109) followed by a pullback; current technical indicators (see below) suggest mild momentum. UAL trades well above its pandemic lows and has outperformed some broader indices this year (its 52-week high is $116 reuters.com).
9 October 2025
Bluejay Diagnostics (BJDX) Stock Skyrockets on Sepsis Test Hopes – What Investors Need to Know

Bluejay Diagnostics (BJDX) Stock Skyrockets on Sepsis Test Hopes – What Investors Need to Know

Company Overview: A Near-Patient Diagnostics Specialist Bluejay Diagnostics, Inc. is a small Massachusetts-based medical diagnostics company focused on rapid near-patient testing solutions for critical care settings stocktitan.net. The company’s mission is to improve emergency and intensive care outcomes by enabling faster, point-of-care testing for life-threatening conditions like sepsis stocktitan.net. Bluejay’s flagship product-in-development is the Symphony system – an automated, “sample-to-result” analyzer that uses disposable cartridges to measure key biomarkers from a patient’s blood sample in minutes bluejaydx.com bluejaydx.com. Symphony’s first target analyte is interleukin-6 (IL-6), an inflammatory marker that rises during infection and sepsis. In hospitals today, diagnosing sepsis early
AI Drug Discovery Goldmine? Inside Recursion Pharma’s Wild Stock Surge and What’s Next

AI Drug Discovery Goldmine? Inside Recursion Pharma’s Wild Stock Surge and What’s Next

Latest News (Oct 7–Oct 9, 2025) Stock Performance & Technical Analysis After languishing through the summer, Recursion’s share price came to life in early October 2025. By Oct 8 the stock had rebounded to around $6.09 insidermonkey.com, putting it near the middle of its volatile 52-week range ($3.97 – $10.87) ts2.tech. For context, RXRX had traded in the double-digits when AI hype in biotech peaked earlier in the year, then slid into the high-$3s during industry sell-offs ts2.tech. Even after this week’s pop, shares remain ~30% lower than a year ago (amid a broader biotech downturn) ts2.tech. Such dramatic swings
American Airlines (AAL) Stock Takes Off on Travel Demand – Will It Keep Climbing or Hit Turbulence?

American Airlines (AAL) Stock Takes Off on Travel Demand – Will It Keep Climbing or Hit Turbulence?

Stock Price and Recent Performance American Airlines’ stock has been on a turbulent ride in 2025. After starting the year in the high teens, AAL has sunk into the low double-digits – recently closing around $11.81 marketbeat.com. The slide accelerated in September amid soft travel demand and pessimistic guidance. As of early October, shares were down over 34% year-to-date (vastly underperforming the S&P 500) and about 15% lower in the past month alone marketbeat.com. This steep drop reflects both company-specific challenges and broader sector headwinds (from rising costs to economic jitters). This week, however, brought a glimmer of relief. American’s
9 October 2025
Serve Robotics (SERV) Stock Soars on DoorDash Deal – The Next Big Bet in AI Delivery?

Serve Robotics (SERV) Stock Soars on DoorDash Deal – The Next Big Bet in AI Delivery?

Latest News & Developments (October 2025) Serve Robotics grabbed headlines this week with a major new partnership announcement. On October 9, 2025, the company revealed a deal with DoorDash to deploy Serve’s sidewalk delivery robots for food orders on the DoorDash platform investing.com. Initially rolling out in Los Angeles, the pilot means DoorDash customers from select restaurants may have their meals delivered by a Serve robot investing.com. This is a strategic expansion beyond Serve’s exclusive relationship with Uber Eats to date. “This partnership enables us to go to cities where DoorDash is the dominant player… we’re looking for more demand,

Stock Market Today

Hongkong Land (SGX:H78) slides 4% despite fresh buyback as March results loom

Hongkong Land (SGX:H78) slides 4% despite fresh buyback as March results loom

8 February 2026
Hongkong Land shares fell 4.2% to $8.18 Friday, reversing earlier gains after hitting a decade high of $9.12 on Feb. 4. The company disclosed repurchases of 170,000 shares for cancellation at average prices above Friday’s close. Investors await March 5 annual results and details on an expanded $650 million buyback program. Trading volume stayed high.
Go toTop